| 2025-05-01 | -20.7% | legal | SEC EDGAR | BDX 8-K: 2.02 and (SEC Filing) |
| 2025-05-01 | -20.7% | news | MarketWatch | Medical-products maker Becton Dickinson says cuts in global research funding have hurt sales - MarketWatch |
| 2025-08-07 | +11.5% | legal | SEC EDGAR | BDX 8-K: 2.02 and (SEC Filing) |
| 2026-02-10 | +11.1% | earnings | Seeking Alpha | Becton, Dickinson and Company: A Q1 2026 Earnings And Post Spin-Off Examination |
| 2026-02-10 | +11.1% | legal | SEC EDGAR | BDX 8-K: 8.01 and (SEC Filing) |
| 2026-02-10 | +11.1% | earnings | Seeking Alpha | Becton, Dickinson and Company: A Q1 2026 Earnings And Post Spin-Off Examination - Seeking Alpha |
| 2026-02-10 | +11.1% | news | Benzinga | What's Going On With Becton Dickinson Stock Tuesday? - Becton Dickinson (NYSE:BDX) - Benzinga |
| 2026-02-10 | +11.1% | news | Finviz | Jim Cramer on Becton, Dickinson: "I Kind of Really Like the New Company" - Finviz |
| 2023-11-09 | -9.1% | legal | SEC EDGAR | BDX 8-K: 2.02 and (SEC Filing) |
| 2025-02-05 | -7.0% | legal | SEC EDGAR | BDX 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-02-03 | +6.6% | legal | SEC EDGAR | BDX 8-K: 2.02 and (SEC Filing) |
| 2023-07-24 | +6.3% | legal | SEC EDGAR | BDX 8-K: 5.02 (SEC Filing) |
| 2021-08-05 | -6.2% | legal | SEC EDGAR | BDX 8-K: 8.01 and (SEC Filing) |
| 2021-08-05 | -6.2% | legal | SEC EDGAR | BDX 8-K: 2.02, 5.02, 7.01 (SEC Filing) |
| 2022-05-05 | +5.9% | legal | SEC EDGAR | BDX 8-K: 2.02 and (SEC Filing) |
| 2021-05-06 | -5.7% | legal | SEC EDGAR | BDX 8-K: 8.01 and (SEC Filing) |
| 2021-05-06 | -5.7% | legal | SEC EDGAR | BDX 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-12-10 | +5.3% | M&A | Seeking Alpha | Waters raised to Outperform at Wolfe on BD Life Sciences deal |
| 2023-05-04 | -4.9% | legal | SEC EDGAR | BDX 8-K: 2.02 and (SEC Filing) |
| 2024-11-07 | -4.7% | legal | SEC EDGAR | BDX 8-K: 2.02 and (SEC Filing) |
| 2022-04-18 | -4.7% | legal | SEC EDGAR | BDX 8-K: 8.01 (SEC Filing) |
| 2022-04-06 | +4.5% | legal | SEC EDGAR | BDX 8-K: 5.02, 7.01, 8.01 (SEC Filing) |
| 2026-02-03 | +4.3% | M&A | Seeking Alpha | Becton, Dickinson resumed at buy at Citi on biosciences unit spinoff |
| 2026-02-03 | +4.3% | news | Finviz | Piper Sandler Highlights Upcoming Segment Transition at Becton Dickinson (BDX) - Finviz |
| 2022-08-04 | +4.0% | legal | SEC EDGAR | BDX 8-K: 2.02 and (SEC Filing) |
| 2026-02-09 | +3.8% | earnings | Seeking Alpha | Becton Dickinson outlines $12.35–$12.65 EPS guidance for 2026 with $4B cash deployment following Waters transaction |
| 2026-02-09 | +3.8% | earnings | Seeking Alpha | Becton, Dickinson and Company (BDX) Q1 2026 Earnings Call Transcript |
| 2026-02-09 | +3.8% | earnings | Seeking Alpha | Becton, Dickinson and Company 2026 Q1 - Results - Earnings Call Presentation |
| 2026-02-09 | +3.8% | earnings | Seeking Alpha | BD slips despite Q1 beat as life sciences unit underperforms |
| 2026-02-09 | +3.8% | earnings | Seeking Alpha | Becton, Dickinson beats top-line and bottom-line estimates; updates FY26 EPS outlook |
| 2026-02-09 | +3.8% | legal | SEC EDGAR | BDX 8-K: 1.01, 5.02, 7.01, 8.01 (SEC Filing) |
| 2026-02-09 | +3.8% | legal | SEC EDGAR | BDX 8-K: 2.02 and (SEC Filing) |
| 2026-02-09 | +3.8% | earnings | ChartMill | BECTON DICKINSON AND CO (NYSE:BDX) Beats Q1 FY2026 Estimates but Shares Fall in Pre-Market - ChartMill |
| 2026-02-09 | +3.8% | earnings | Reuters | Becton Dickinson lowers 2026 profit forecast, shares fall - Reuters |
| 2026-02-09 | +3.8% | news | Benzinga | Becton Dickinson, ON Semiconductor And 3 Stocks To Watch Heading Into Monday - Becton Dickinson (NYSE:BDX - Benzinga |
| 2026-02-09 | +3.8% | earnings | Benzinga | Becton Dickinson Slashes Profit Outlook Post-Spinoff - Becton Dickinson (NYSE:BDX) - Benzinga |
| 2026-02-09 | +3.8% | earnings | Benzinga | Dow Falls 250 Points; Becton Dickinson Posts Upbeat Earnings - Benzinga |
| 2023-02-02 | -3.7% | legal | SEC EDGAR | BDX 8-K: 2.02 and (SEC Filing) |
| 2026-01-14 | +3.6% | analyst | Seeking Alpha | Becton, Dickinson And Company: Rightfully Re-Rated (Downgrade) |
| 2024-08-01 | +3.6% | legal | SEC EDGAR | BDX 8-K: 2.02 and (SEC Filing) |
| 2026-02-25 | -3.5% | legal | SEC EDGAR | BDX 8-K: 8.01 and (SEC Filing) |
| 2023-01-06 | -3.4% | legal | SEC EDGAR | BDX 8-K: 5.02, 7.01 (SEC Filing) |
| 2024-02-01 | -3.1% | legal | SEC EDGAR | BDX 8-K: 2.02 and (SEC Filing) |
| 2026-01-13 | +3.0% | news | Seeking Alpha | BD invests $110M in Nebraska to boost U.S. drug delivery solutions |
| 2023-02-13 | -2.9% | legal | SEC EDGAR | BDX 8-K: 1.01, 2.03 (SEC Filing) |
| 2022-04-14 | -2.8% | legal | SEC EDGAR | BDX 8-K: 2.02 and (SEC Filing) |
| 2026-04-23 | -2.6% | earnings | Zacks | West Pharmaceutical Services (WST) Q1 Earnings and Revenues Beat Estimates |
| 2026-02-18 | +2.6% | news | GuruFocus | Insider Sell: Bertram Scott Sells Shares of Becton Dickinson & C - GuruFocus |
| 2026-03-31 | -2.6% | earnings | MarketBeat | Pacific Capital Partners Ltd Buys 8,250 Shares of Becton, Dickinson and Company $BDX - MarketBeat |
| 2021-08-11 | +2.6% | legal | SEC EDGAR | BDX 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-05-02 | -2.4% | earnings | Yahoo Finance | Becton Dickinson & Co (BDX) Q2 2025 Earnings Call Highlights: Strong EPS Growth Amid ... - Yahoo Finance |
| 2026-04-09 | -2.3% | legal | SEC EDGAR | BDX 8-K: 5.02, 7.01 (SEC Filing) |
| 2021-11-30 | +2.2% | legal | Becton Dickinson | 4: Statement of changes in beneficial ownership of securities - Becton Dickinson |
| 2022-11-10 | -2.2% | legal | SEC EDGAR | BDX 8-K: 2.02 and (SEC Filing) |
| 2021-11-04 | -2.2% | legal | SEC EDGAR | BDX 8-K: 2.02 and (SEC Filing) |
| 2025-01-10 | +2.1% | legal | SEC EDGAR | BDX 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-01-23 | +2.1% | news | Intellectia AI | BDX Forecast — Price Prediction for 2026. Should I Buy BDX? - Intellectia AI |
| 2025-03-27 | +2.1% | legal | SEC EDGAR | BDX 8-K: 5.02 (SEC Filing) |
| 2026-02-06 | -2.0% | earnings | Seeking Alpha | Becton, Dickinson Q1 2026 Earnings Preview |
| 2026-02-02 | +1.8% | news | Finviz | Becton, Dickinson and Company (BDX): A Bull Case Theory - Finviz |
| 2026-01-23 | -1.8% | news | Seeking Alpha | Novo Nordisk Wegovy pill uptake negatively impacts syringe makers |
| 2026-01-23 | -1.8% | analyst | ChartMill | Becton, Dickinson and Co (NYSE:BDX) Shows High Technical and Setup Ratings for Potential Breakout - ChartMill |
| 2025-11-06 | +1.8% | earnings | Seeking Alpha | Becton Dickinson outlines $200M cost reduction and targets $14.75–$15.05 EPS for 2026 while expanding sales force |
| 2025-11-06 | +1.8% | earnings | Seeking Alpha | Becton, Dickinson and Company (BDX) Q4 2025 Earnings Call Transcript |
| 2025-11-06 | +1.8% | earnings | Seeking Alpha | Becton, Dickinson reports mixed Q4 results; initiates FY26 outlook |
| 2025-11-06 | +1.8% | news | Seeking Alpha | Becton, Dickinson declares $1.05 dividend |
| 2025-11-06 | +1.8% | legal | SEC EDGAR | BDX 8-K: 2.02 and (SEC Filing) |
| 2025-11-06 | +1.8% | earnings | ChartMill | BECTON DICKINSON AND CO (NYSE:BDX) Shares Slide on Q4 Revenue Miss Despite EPS Meet - ChartMill |
| 2026-04-22 | -1.8% | news | GlobeNewswire | $10+ Bn Microbiology Testing Market Analysis by Product, Technology, End User - Global Forecast to 2031 |
| 2026-04-22 | -1.8% | executive | Zacks | Zacks Industry Outlook Highlights Cardinal, Becton and The Cooper |
| 2024-05-02 | -1.8% | legal | SEC EDGAR | BDX 8-K: 2.02 and (SEC Filing) |
| 2026-01-02 | +1.7% | news | AD HOC NEWS | The Truth About Becton Dickinson & Co (BDX): Quiet Giant Or Sleeper Stock You’re Sleeping On? - AD HOC NEWS |
| 2024-08-30 | +1.6% | legal | SEC EDGAR | BDX 8-K: 5.02 and (SEC Filing) |
| 2025-07-14 | +1.6% | legal | SEC EDGAR | BDX 8-K: 1.01 and (SEC Filing) |
| 2025-07-14 | +1.6% | M&A | MarketWatch | Becton Dickinson gets its spinoff deal, but the stock is still falling - MarketWatch |
| 2023-07-14 | -1.6% | news | intelligentinvestor.com.au | Becton Dickinson and Co (NYSE:BDX) - intelligentinvestor.com.au |
| 2025-12-01 | -1.6% | legal | SEC EDGAR | BDX 8-K: 5.02 and (SEC Filing) |
| 2026-04-17 | +1.5% | news | Motley Fool | The Healthcare Stock Built for Investors Who Prioritize Capital Preservation |
| 2025-10-15 | -1.4% | executive | Seeking Alpha | BDX appoints Vitor Roque as interim CFO |
| 2025-10-15 | -1.4% | earnings | Seeking Alpha | Becton, Dickinson slips as FQ4, 2025 revenue estimates just below consensus |
| 2025-10-15 | -1.4% | legal | SEC EDGAR | BDX 8-K: 2.02, 5.02, 7.01 (SEC Filing) |
| 2025-10-15 | -1.4% | executive | Becton Dickinson | BD Announces CFO Transition Plan :: Becton, Dickinson and Company (BDX) - Becton Dickinson |
| 2025-11-17 | +1.4% | legal | SEC EDGAR | BDX 8-K: 5.02 and (SEC Filing) |
| 2025-10-22 | -1.4% | news | Yahoo Finance | What Makes Becton Dickinson & Co. (BDX) a Good Investment? - Yahoo Finance |
| 2025-12-18 | -1.3% | executive | Quiver Quantitative | BECTON DICKINSON & CO ($BDX) CEO 2025 Pay Revealed - Quiver Quantitative |
| 2023-08-03 | -1.2% | legal | SEC EDGAR | BDX 8-K: 2.02 and (SEC Filing) |
| 2023-03-10 | +1.2% | legal | SEC EDGAR | BDX 8-K: 1.01, 2.03 (SEC Filing) |
| 2026-04-02 | -1.2% | legal | SEC EDGAR | BDX 8-K: 2.02 and (SEC Filing) |
| 2026-04-02 | -1.2% | news | MarketWatch | Becton Dickinson & Co. stock underperforms Thursday when compared to competitors - MarketWatch |
| 2026-02-12 | -1.1% | news | Sure Dividend | Dividend Aristocrats In Focus: Becton, Dickinson & Co. - Sure Dividend |
| 2026-01-27 | -1.1% | news | Seeking Alpha | Becton, Dickinson declares $1.05 dividend |
| 2026-01-27 | -1.1% | M&A | Stock Titan | BD carves out biosciences arm, $4B Waters deal nears Feb. 9 - Stock Titan |
| 2026-01-27 | -1.1% | news | Stock Titan | BD to pay $4.20 a share, authorizes buyback of 10M more shares - Stock Titan |
| 2024-02-27 | -1.1% | legal | SEC EDGAR | BDX 8-K: 5.02, 7.01 (SEC Filing) |
| 2021-09-13 | +1.1% | news | The Motley Fool | Becton, Dickinson - BDX - Stock Price & News - The Motley Fool |
| 2026-03-10 | -1.1% | news | Seeking Alpha | Becton, Dickinson and Company (BDX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript |
| 2025-10-20 | -1.1% | news | Seeking Alpha | Becton, Dickinson and Company: A Dividend Idea With Diverse Medtech Portfolio To Meet Future Demand |
| 2022-03-31 | +1.1% | legal | SEC EDGAR | BDX 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-12-22 | -1.0% | news | Seeking Alpha | Becton, Dickinson accused of hindering competition in hernia mesh market |
| 2026-02-19 | +1.0% | M&A | Stock Titan | Walgreens deal veteran Lanesha Minnix to lead BD legal and public affairs - Stock Titan |
| 2021-08-13 | +1.0% | legal | SEC EDGAR | BDX 8-K: 1.01, 2.03, 8.01 (SEC Filing) |
| 2021-08-30 | +1.0% | legal | SEC EDGAR | BDX 8-K: 5.02 (SEC Filing) |
| 2025-09-18 | -1.0% | legal | SEC EDGAR | BDX 8-K: 1.01, 2.03 (SEC Filing) |
| 2022-08-08 | +0.9% | legal | SEC EDGAR | BDX 8-K: 8.01 and (SEC Filing) |
| 2021-09-27 | +0.9% | legal | SEC EDGAR | BDX 8-K: 1.01, 2.03 (SEC Filing) |
| 2025-10-09 | -0.8% | earnings | Stock Titan | Nov. 6 webcast: Q4 & FY2025 results — BD to discuss financials, operations and strategy - Stock Titan |
| 2025-02-08 | -0.8% | news | CNBC | Starboard pushes an open door at Becton Dickinson as company seeks to separate its biosciences unit - CNBC |
| 2024-02-06 | +0.7% | legal | SEC EDGAR | BDX 8-K: 8.01 and (SEC Filing) |
| 2025-11-07 | +0.7% | earnings | Seeking Alpha | Becton, Dickinson and Company: Strong Earnings But Murky Outlook |
| 2024-02-15 | +0.7% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2022-08-09 | -0.7% | legal | SEC EDGAR | BDX 8-K: 8.01 and (SEC Filing) |
| 2022-05-31 | -0.6% | legal | SEC EDGAR | BDX 8-K: 2.02 and (SEC Filing) |
| 2023-11-27 | -0.6% | legal | SEC EDGAR | BDX 8-K: 5.02 and (SEC Filing) |
| 2025-11-18 | +0.6% | earnings | Seeking Alpha | 1578 Partners initiates new position in Becton, Dickinson and Company in Q3 |
| 2025-11-18 | +0.6% | news | Seeking Alpha | Becton, Dickinson: Our New, Long, Special Situation Investment |
| 2025-11-08 | +0.6% | earnings | Seeking Alpha | Becton, Dickinson and Company 2025 Q4 - Results - Earnings Call Presentation |
| 2021-08-19 | -0.6% | legal | SEC EDGAR | BDX 8-K: 8.01 and (SEC Filing) |
| 2021-08-10 | +0.5% | legal | SEC EDGAR | BDX 8-K: 8.01 and (SEC Filing) |
| 2021-07-12 | -0.5% | legal | SEC EDGAR | BDX 8-K: 5.02 and (SEC Filing) |
| 2026-02-13 | -0.5% | news | Finviz | Citi Raises Becton Dickinson (BDX) PT to $198 after Life Sciences Sale Update - Finviz |
| 2024-06-07 | -0.5% | legal | SEC EDGAR | BDX 8-K: 1.01, 2.03 (SEC Filing) |
| 2021-10-22 | -0.5% | legal | SEC EDGAR | BDX 8-K: 5.02 (SEC Filing) |
| 2026-03-14 | -0.4% | news | Seeking Alpha | U.S. to ease restrictions on carcinogenic gas used for sterilizing medical devices |
| 2025-10-13 | -0.4% | earnings | Seeking Alpha | ClearBridge Value Strategy adds AMZN, TSM, CRM, exits INTC, ABBV, EXPE among Q3 moves |
| 2024-07-12 | -0.4% | legal | SEC EDGAR | BDX 8-K: 1.01, 2.03 (SEC Filing) |
| 2026-02-05 | +0.4% | legal | SEC EDGAR | BDX 8-K: 3.02, 5.03 (SEC Filing) |
| 2022-08-22 | -0.4% | legal | SEC EDGAR | BDX 8-K: 8.01 and (SEC Filing) |
| 2026-01-15 | -0.3% | legal | Stock Titan | FDA clears new BD device aimed at improving breast biopsies for patients - Stock Titan |
| 2026-04-20 | -0.3% | news | Zacks | Here Are 3 Medical Supply Stocks to Consider Amid Rising Prospects |
| 2026-04-20 | -0.3% | earnings | Barchart | What You Need to Know Ahead of Becton, Dickinson and Company's Earnings Release |
| 2026-04-20 | -0.3% | news | Seeking Alpha | Becton, Dickinson: Value Or Overvalued Even Now? |
| 2026-04-19 | +0.3% | news | Simply Wall St. | Becton Dickinson Wins Supply Chain Honors As Valuation Appears Undemanding |
| 2026-04-18 | +0.3% | news | GuruFocus | KANAWHA CAPITAL MANAGEMENT LLC's Becton Dickinson & Co(BDX) Holding History - GuruFocus |
| 2026-01-16 | -0.3% | news | Investing.com | Becton Dickinson EVP Garrison sells $334,005 in BDX stock - Investing.com |
| 2025-08-26 | -0.3% | news | GuruFocus | Insider Sell: Michael Feld Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus |
| 2025-04-27 | -0.3% | news | Seeking Alpha | Becton, Dickinson and Company: It's Wait And See For Me (NYSE:BDX) - Seeking Alpha |
| 2026-01-07 | +0.2% | news | AD HOC NEWS | The Truth About Becton Dickinson and Co (BDX): Quiet Healthcare Giant, Loud Money Moves - AD HOC NEWS |
| 2023-01-25 | +0.2% | legal | SEC EDGAR | BDX 8-K: 1.01, 2.03 (SEC Filing) |
| 2022-08-25 | +0.2% | legal | SEC EDGAR | BDX 8-K: 5.02, 7.01 (SEC Filing) |
| 2022-03-26 | +0.2% | news | marketscreener.com | Becton, Dickinson and Company Stock (BDX) - Quote Nyse - marketscreener.com |
| 2026-01-30 | +0.2% | legal | SEC EDGAR | BDX 8-K: 5.02, 5.07 (SEC Filing) |
| 2025-11-05 | -0.2% | earnings | Seeking Alpha | Becton, Dickinson Q4 2025 Earnings Preview |
| 2023-02-07 | -0.2% | legal | SEC EDGAR | BDX 8-K: 8.01 and (SEC Filing) |
| 2022-03-01 | +0.2% | legal | SEC EDGAR | BDX 8-K: 5.02 (SEC Filing) |
| 2025-11-25 | -0.1% | legal | TradingView | BECTON DICKINSON & CO SEC 10-K Report - TradingView |
| 2022-03-21 | -0.1% | legal | SEC EDGAR | BDX 8-K: 3.02, 5.03, 8.01 (SEC Filing) |
| 2023-01-30 | -0.0% | legal | SEC EDGAR | BDX 8-K: 5.02, 5.07 (SEC Filing) |
| 2026-04-26 | — | news | Insider Monkey | Piper Sandler Trims Becton Dickinson (BDX) PT on Model Revisions |
| 2026-04-24 | — | earnings | GuruFocus.com | Becton Dickinson at 13x Earnings: MedTech's Most Mispriced Compounder |
| 2026-04-24 | — | news | Insider Monkey | Becton Dickinson and Company (BDX): Gold Standard Defensive Stock |
| 2026-04-24 | — | news | MarketWatch | Becton Dickinson & Co. stock underperforms Friday when compared to competitors - MarketWatch |